| Acronym | MECCLANT-C |
|---|---|
| Number | 2016-000254-35 |
| Protocol Link | https://www.emkapes.gr/pdf/MECCLANT-protocol-colon-new-cor-gouvas-brief.pdf |
| Public Trial Registry Link | https://www.emkapes-projects.eu/Apps/redcap/ |
| Status | Open/recruiting |
| Category | Colorectal Cancer - Colonic Specific |
| Treatment Course | Surgery |
| The MECCLANT-C trial is a phase II prospective, randomized, two-arm, comparative, multicenter study supported by the Gastro-Intestinal Cancer Srudy Group (GIC-SG). Patients are allocated in two groups: no bowel preparation and mechanical bowel cleansing plus oral antibiotics. Primary end points: Incisional surgical site infection and Secondary end points: anastomotic leakage, 30-day mortality, 30-day morbidity, paralytic ileus, length of hospital stay, radmission rate. |
|
Xynos Evangelos Professor |
| Profile Link |
|
Gastro-Intestinal Cancer Study Group 19 Michelidaki str Herakleion 71202 Greece |
| Website |
ESCP Secretariat
c/o MCI UK Ltd
Unit 24/22 South
Building 4000, Langstone Park
Langstone Road
Havant PO9 1SA
01730 715 208
